Stryker Corporation $SYK Shares Acquired by Professional Advisory Services Inc.

Key Points

• Professional Advisory Services increased its Stryker stake by 31.1% in the second quarter, holding 83,421 shares worth approximately $26.3 million. Institutional investors collectively own 77.09% of SYK.
• Analysts maintain a generally positive view, with one Strong Buy, 17 Buy and five Hold ratings, producing a “Moderate Buy” consensus and an average price target of $386.28.
• Stryker reported quarterly EPS of $3.69, beating estimates of $3.49, while revenue rose 9.4% year over year to $6.59 billion. The company also declared a quarterly dividend of $0.88 per share, representing a 1.0% annualized yield.

Professional Advisory Services Inc. lifted its position in shares of Stryker Corporation (NYSE:SYK - Free Report) by 31.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 83,421 shares of the medical technology company's stock after purchasing an additional 19,767 shares during the period. Stryker comprises approximately 3.1% of Professional Advisory Services Inc.'s portfolio, making the stock its 15th largest position. Professional Advisory Services Inc.'s holdings in Stryker were worth $26,264,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of SYK. VanderPol Investments L.L.C. raised its holdings in Stryker by 1.4% during the 4th quarter. VanderPol Investments L.L.C. now owns 2,084 shares of the medical technology company's stock worth $732,000 after buying an additional 28 shares during the period. Rossby Financial LCC boosted its holdings in shares of Stryker by 6.6% in the fourth quarter. Rossby Financial LCC now owns 451 shares of the medical technology company's stock worth $159,000 after buying an additional 28 shares during the period. KCM Investment Advisors LLC increased its position in shares of Stryker by 1.5% in the fourth quarter. KCM Investment Advisors LLC now owns 1,857 shares of the medical technology company's stock worth $653,000 after acquiring an additional 28 shares in the last quarter. Tcfg Wealth Management LLC raised its holdings in shares of Stryker by 2.7% during the third quarter. Tcfg Wealth Management LLC now owns 1,091 shares of the medical technology company's stock valued at $403,000 after acquiring an additional 29 shares during the period. Finally, Sompo Asset Management Co. Ltd. lifted its position in shares of Stryker by 1.3% in the 2nd quarter. Sompo Asset Management Co. Ltd. now owns 2,390 shares of the medical technology company's stock valued at $946,000 after acquiring an additional 30 shares in the last quarter. Hedge funds and other institutional investors own 77.09% of the company's stock.

Analyst Upgrades and Downgrades

SYK has been the topic of several research analyst reports. Canaccord Genuity Group lowered their price objective on shares of Stryker from $435.00 to $400.00 and set a "buy" rating on the stock in a research report on Friday, May 1st. Raymond James Financial set a $370.00 target price on Stryker in a report on Friday, July 31st. Sanford C. Bernstein set a $410.00 price target on Stryker in a report on Friday, May 1st. Royal Bank Of Canada reduced their price objective on Stryker from $435.00 to $420.00 and set an "outperform" rating for the company in a research note on Friday, July 31st. Finally, The Goldman Sachs Group reiterated a "neutral" rating and issued a $361.00 target price on shares of Stryker in a report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and five have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $386.28.

Insider Activity

In other news, VP Robert S. Fletcher sold 4,544 shares of the firm's stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the transaction, the vice president owned 10,582 shares in the company, valued at approximately $3,247,298.34. This trade represents a 30.04% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP M Kathryn Fink sold 5,220 shares of Stryker stock in a transaction on Monday, May 11th. The shares were sold at an average price of $283.85, for a total transaction of $1,481,697.00. Following the completion of the sale, the vice president directly owned 13,137 shares of the company's stock, valued at approximately $3,728,937.45. The trade was a 28.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 323,264 shares of company stock worth $100,659,489. 4.60% of the stock is owned by corporate insiders.

Stryker Stock Up 0.4%

SYK opened at $338.85 on Friday. The company has a market capitalization of $129.97 billion, a PE ratio of 35.11, a price-to-earnings-growth ratio of 2.15 and a beta of 0.76. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.16 and a quick ratio of 1.33. Stryker Corporation has a fifty-two week low of $281.00 and a fifty-two week high of $396.86. The business has a 50-day moving average of $320.11 and a 200-day moving average of $334.13.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The business had revenue of $6.59 billion during the quarter, compared to analysts' expectations of $6.58 billion. During the same quarter in the previous year, the business posted $3.13 EPS. The firm's quarterly revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. Equities research analysts forecast that Stryker Corporation will post 15.02 EPS for the current fiscal year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 annualized dividend and a dividend yield of 1.0%. Stryker's dividend payout ratio is 36.48%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source